DK49889D0 - Forhindring eller bedring af katarakt ad kemisk vej ved hjaelp af fasesepareringsinhibitorer - Google Patents

Forhindring eller bedring af katarakt ad kemisk vej ved hjaelp af fasesepareringsinhibitorer

Info

Publication number
DK49889D0
DK49889D0 DK049889A DK49889A DK49889D0 DK 49889 D0 DK49889 D0 DK 49889D0 DK 049889 A DK049889 A DK 049889A DK 49889 A DK49889 A DK 49889A DK 49889 D0 DK49889 D0 DK 49889D0
Authority
DK
Denmark
Prior art keywords
cataract
inhibitors
prevention
improvement
phase safety
Prior art date
Application number
DK049889A
Other languages
English (en)
Other versions
DK49889A (da
Inventor
John I Clark
George B Benedeck
Roelant J Siezan
John A Thomson
Simon H Friedman
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of DK49889D0 publication Critical patent/DK49889D0/da
Publication of DK49889A publication Critical patent/DK49889A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Eyeglasses (AREA)
DK049889A 1987-06-04 1989-02-03 Forhindring eller bedring af katarakt ad kemisk vej ved hjaelp af fasesepareringsinhibitorer DK49889A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5814087A 1987-06-04 1987-06-04
US19885088A 1988-05-26 1988-05-26
PCT/US1988/001918 WO1988009660A2 (en) 1987-06-04 1988-06-03 Chemical prevention or reversal of cataract by phase separation inhibitors

Publications (2)

Publication Number Publication Date
DK49889D0 true DK49889D0 (da) 1989-02-03
DK49889A DK49889A (da) 1989-03-10

Family

ID=26737284

Family Applications (1)

Application Number Title Priority Date Filing Date
DK049889A DK49889A (da) 1987-06-04 1989-02-03 Forhindring eller bedring af katarakt ad kemisk vej ved hjaelp af fasesepareringsinhibitorer

Country Status (9)

Country Link
US (1) US5284874A (da)
EP (1) EP0316438B1 (da)
JP (1) JPH02500370A (da)
AU (1) AU2089792A (da)
CA (1) CA1322526C (da)
DE (1) DE3883712T2 (da)
DK (1) DK49889A (da)
FI (1) FI890524A0 (da)
WO (1) WO1988009660A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338545A (en) * 1987-06-04 1994-08-16 Oculon Corporation Chemical prevention or reversal of cataract by phase separation inhibitors
WO1994026259A1 (en) * 1993-05-12 1994-11-24 Oculon Corporation Chemical prevention or reversal of cataract by phase separation inhibitors
ATE315939T1 (de) * 1993-11-19 2006-02-15 Univ Sydney Verfahren zur prophylaxe oder kontrolle des katarakts
CN100391448C (zh) * 2003-11-19 2008-06-04 奥加生物药业(I.P.1)有限公司 提高乙醇代谢和减轻宿醉效应的物质和方法
WO2005060342A2 (en) * 2003-12-19 2005-07-07 Omega Bio-Pharma International Ltd. Cysteamine compounds for treating allergy
TWI350751B (en) * 2003-12-19 2011-10-21 Omega Bio Pharma Ip3 Ltd Pharmaceutical compositions for treating diabetes
WO2005067899A2 (en) * 2004-01-13 2005-07-28 Omega Bio-Pharma (I.P.2) Limited Methods for treating stress and affecting biological immune systems using a cysteamine compound
AU2005240122B2 (en) * 2004-05-03 2011-02-17 Omega Bio-Pharma (I.P.3) Limited Cysteamines for treating complications of hypercholesterolemia and diabetes
KR20070026873A (ko) * 2004-06-30 2007-03-08 오메가 바이오 파마(아이.피.1) 리미티드 패류의 건강, 면역성 및 성장을 증진하기 위한 물질과 방법
AU2006314062A1 (en) * 2005-11-21 2007-05-24 Mordechai Sharir Succinimide derivatives as ocular hypotensive agents
US8853257B2 (en) 2005-11-21 2014-10-07 Mordechai Sharir Succinimide derivatives as ocular hypotensive agents
US20070172514A1 (en) * 2006-01-20 2007-07-26 Francis Chi Materials and methods for improving livestock productivity

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124508A (en) * 1964-03-10 N-methylaminoethyl
US2411572A (en) * 1941-06-25 1946-11-26 Rca Corp Pulse echo system
US3892824A (en) * 1968-12-16 1975-07-01 Southern Res Inst S-{107 -({107 -aminoalkylamino)alkyl dihydrogen phosphorothioates
US3920810A (en) * 1974-04-23 1975-11-18 Burton Parsons And Company Inc Polyacrylamide containing ophthalmic solutions
US4080264A (en) * 1976-03-01 1978-03-21 Massachusetts Institute Of Technology Immunoassay by light scattering spectroscopy
US4350677A (en) * 1976-11-22 1982-09-21 Massachusetts Institute Of Technology Reagent for optimizing agglutination
US4424216A (en) * 1979-07-31 1984-01-03 The Rockefeller University Method for the reduction of mucin viscosity
US4474817A (en) * 1980-02-29 1984-10-02 Massachusetts Institute Of Technology Process for preventing or reversing cataract formation
US4351826A (en) * 1980-02-29 1982-09-28 Massachusetts Institute Of Technology Process for preventing or reversing cataract formation using acrylamides
US4526789A (en) * 1980-02-29 1985-07-02 Massachusetts Institute Of Technology Process for preventing or reversing cataract formation
US4350163A (en) * 1980-05-29 1982-09-21 Ford Jr Norman C Method and apparatus for analyzing contaminants in aqueous humor
IT1189052B (it) * 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
DE3306981C2 (de) * 1983-02-28 1987-11-12 Wolfram 8048 Haimhausen Weinberg Vorrichtung zur Photokoagulation von biologischem Gewebe
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US4611074A (en) * 1983-12-06 1986-09-09 Southern Research Institute (Alkylsulfonyl)methanesulfonates as anticancer agents
JPS60139618A (ja) * 1983-12-28 1985-07-24 Sogo Yatsukou Kk 白内障治療薬
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
US4727174A (en) * 1984-11-19 1988-02-23 Southern Research Institute (Alkylsulfonyl)methanesulfonates as anticancer agents
US4665089A (en) * 1985-03-21 1987-05-12 Massachusetts Institute Of Technology Process for preventing or reversing cataract formation using protein modification reagents
JPS61268229A (ja) * 1985-05-22 1986-11-27 興和株式会社 眼科測定装置
US4702576A (en) * 1985-09-27 1987-10-27 Cambridge Instruments Inc. Ocular scattering analyzer

Also Published As

Publication number Publication date
WO1988009660A2 (en) 1988-12-15
FI890524A (fi) 1989-02-03
US5284874A (en) 1994-02-08
JPH02500370A (ja) 1990-02-08
DE3883712T2 (de) 1993-12-16
DE3883712D1 (de) 1993-10-07
CA1322526C (en) 1993-09-28
WO1988009660A3 (en) 1989-02-09
EP0316438A1 (en) 1989-05-24
FI890524A0 (fi) 1989-02-03
EP0316438B1 (en) 1993-09-01
AU2089792A (en) 1992-10-29
DK49889A (da) 1989-03-10

Similar Documents

Publication Publication Date Title
DK38289A (da) Fremgangsmaade til selektiv haemning af hiv
NO302278B1 (no) Fremgangsmåte ved separasjon av ilmenitt
NO925026D0 (no) Fremgangsmaate ved fremstilling av ultratynne uorganiske membraner
DK519384A (da) Fremgangsmaade til forebyggelse eller inhibering af korrosion
DK49889A (da) Forhindring eller bedring af katarakt ad kemisk vej ved hjaelp af fasesepareringsinhibitorer
DK106897A (da) Fremgangsmåde til fremstilling af urinstofderivater
DK97488A (da) Fremgangsmaade til fjernelse af metaller, navnlig tungmetaller, fra spildevand
IT7968035A0 (it) Procedimento per la riutilizzazione dei fanghi di verniciatura
DK364181A (da) Fremgangsmaade til fremstilling af caprolactamderivater
DK160989D0 (da) Pyroteknisk komposition til dannelse af et roegsloer
DK714588A (da) Syrelabile forankringsgrupper til syntese af peptidamider ved fastfasemetoden
DK515283D0 (da) Foring til afstivning af borehuller
DK157758C (da) Fremgangsmaade til fremstilling af penicillansyre-1,1-dioxid ved dehalogenering af 6,6-dibrompenicillansyre-1,1-dioxid
DK533881A (da) Fremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxidazol-2-oxider eller farmekologisk acceptable syreadditionsforbindelser
NO854655L (no) Fremgangsmaate ved fremstilling av flavolignanderivateer.
DK687987D0 (da) Fremgangsmaade til udvinding af ballaststoffer fra druekvas samt produkt fremstillet ved fremgangsmaaden
DK85683D0 (da) Fremgangsmade til fremstilling af bicycliske kondenserede benzoforbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter ved fremgangsmaden
NO812467L (no) Fremgangsmaate ved fremstilling av as-triazinderivater
DK223783A (da) Fremgangsmaade til fremstilling af dihydropyridiner samt mellemprodukter til anvendelse ved fremgangsmaaden
IT7849227A0 (it) Procedimento per la separazione di pirrolidone-2 da polipirrolidone
DK113897A (da) Fremgangsmåde til fremstilling af antihypercholesterolæmiske tetrazolforbindelser
FR2626142B1 (fr) Piege pyrotechnique pour la destruction des taupes
JPS5572502A (en) Method of preventing vibration of bridge girder
NO985895D0 (no) FremgangsmÕte for alkylering av alkyl- eller benzylcyanderivater under tils tedevµrelse af trialkylaminer eller -fosiner
DK57387A (da) Fremgangsmaade til fjernelse af skadelige stoffer fra roeggas

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment